1832 Asset Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-60,600
Closed -$5.01M 676
2024
Q4
$5.01M Buy
+60,600
New +$4.78M ﹤0.01% 376
2024
Q2
Sell
-19
Closed -$1.02K 923
2024
Q1
$1.02K Hold
19
﹤0.01% 859
2023
Q4
$1.01K Buy
+19
New +$926 ﹤0.01% 798

Other funds holding GMED

1832 Asset Management's GMED Position: Q1 2025 in Review

1832 Asset Management sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 60,600 shares — an estimated $5.01M sold.

1832 Asset Management first reported a position in GMED in Q4 2023 and held it in 3 quarters. The position peaked at $5.01M in Q4 2024. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

  • 1832 Asset Management reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
  • 1832 Asset Management sold 60,600 Globus Medical shares in Q1 2025, an estimated $5.01M.
  • 1832 Asset Management first reported a position in Globus Medical in Q4 2023 and held it in 3 quarters.
  • 1832 Asset Management's Globus Medical position peaked at $5.01M in Q4 2024.
  • 514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on 1832 Asset Management's 13F filing for Q1 2025, filed 14 May 2025.